TY - JOUR
T1 - Tissue nonspecific alkaline phosphatase is activated via a two-step mechanism by zinc transport complexes in the early secretory pathway
AU - Fukunaka, Ayako
AU - Kurokawa, Yayoi
AU - Teranishi, Fumie
AU - Sekler, Israel
AU - Oda, Kimimitsu
AU - Ackland, M. Leigh
AU - Faundez, Victor
AU - Hiromura, Makoto
AU - Masuda, Seiji
AU - Nagao, Masaya
AU - Enomoto, Shuichi
AU - Kambe, Taiho
PY - 2011/5/6
Y1 - 2011/5/6
N2 - A number of enzymes become functional by binding to zinc during their journey through the early secretory pathway. The zinc transporters (ZnTs) located there play important roles in this step. We have previously shown that two zinc transport complexes, ZnT5/ZnT6 heterodimers and ZnT7 homo-oligomers, are required for the activation of alkaline phosphatases, by converting them from the apo- to the holo-form. Here, we investigated the molecular mechanisms of this activation. ZnT1 and ZnT4 expressed in chicken DT40 cells did not contribute to the activation of tissue nonspecific alkaline phosphatase (TNAP). The reduced activity of TNAP in DT40 cells deficient in both ZnT complexes was not restored by zinc supplementation nor by exogenous expression of other ZnTs that increase the zinc content in the secretory pathway. Moreover, we showed that expression of ZnT5/ZnT6 heterodimers reconstituted with zinc transport-incompetent ZnT5 mutant failed to restore TNAP activity but could stabilize the TNAP protein as the apo-form, regardless of zinc status. These findings demonstrate that TNAP is activated not simply by passive zinc binding but by an elaborate two-step mechanism via protein stabilization followed by enzyme conversion from the apo- to the holo-form with zinc loaded by ZnT complexes in the early secretory pathway.
AB - A number of enzymes become functional by binding to zinc during their journey through the early secretory pathway. The zinc transporters (ZnTs) located there play important roles in this step. We have previously shown that two zinc transport complexes, ZnT5/ZnT6 heterodimers and ZnT7 homo-oligomers, are required for the activation of alkaline phosphatases, by converting them from the apo- to the holo-form. Here, we investigated the molecular mechanisms of this activation. ZnT1 and ZnT4 expressed in chicken DT40 cells did not contribute to the activation of tissue nonspecific alkaline phosphatase (TNAP). The reduced activity of TNAP in DT40 cells deficient in both ZnT complexes was not restored by zinc supplementation nor by exogenous expression of other ZnTs that increase the zinc content in the secretory pathway. Moreover, we showed that expression of ZnT5/ZnT6 heterodimers reconstituted with zinc transport-incompetent ZnT5 mutant failed to restore TNAP activity but could stabilize the TNAP protein as the apo-form, regardless of zinc status. These findings demonstrate that TNAP is activated not simply by passive zinc binding but by an elaborate two-step mechanism via protein stabilization followed by enzyme conversion from the apo- to the holo-form with zinc loaded by ZnT complexes in the early secretory pathway.
UR - http://www.scopus.com/inward/record.url?scp=79955529543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955529543&partnerID=8YFLogxK
U2 - 10.1074/jbc.M111.227173
DO - 10.1074/jbc.M111.227173
M3 - Article
C2 - 21402707
AN - SCOPUS:79955529543
SN - 0021-9258
VL - 286
SP - 16363
EP - 16373
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 18
ER -